The effect of umeclidinium added to inhaled corticosteroid/long-acting β2-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study. [PDF]
Sousa AR +5 more
europepmc +1 more source
Airway inflammation and asthma control in patients using salbutamol or budesonide/formoterol reliever: a randomised, controlled study. [PDF]
Martin MJ +11 more
europepmc +1 more source
Inhaled Corticosteroids Influence Pulmonary Microbiota in Severe Equine Asthma. [PDF]
Manguin E +4 more
europepmc +1 more source
Antihyperglycemic Drugs and Risk of Asthma Exacerbation in Patients With Asthma and Type 2 Diabetes: A Multinational Retrospective Cohort Study. [PDF]
Hung CT, An CY, Tsai YC, Suk CW, Wu CH.
europepmc +1 more source
Effectiveness and Safety of Budesonide/Formoterol in Asthma: A Systematic Review. [PDF]
Vo NX, Pham HL, Ho HT, Chung KQ, Bui TT.
europepmc +1 more source
Uncontrolled Status, Disease Burden, and Associated Risk Factors Among Patients with Asthma Receiving Medium-to-High Dose ICS or ICS/LABA: A Retrospective Analysis. [PDF]
Shi H, Wang Y, Wang M, Shen D, Huang K.
europepmc +1 more source
Clinical Remission with FF/UMEC/VI Versus ICS/LABA in Uncontrolled Asthma: The PERFORM Pragmatic Randomized Controlled Trial. [PDF]
Noorduyn SG +11 more
europepmc +1 more source
Budesonide/formoterol fumarate dihydrate <i>versus</i> budesonide with a novel suspension technology for uncontrolled asthma: phase 3 LITHOS study. [PDF]
Papi A +12 more
europepmc +1 more source
Adherence to Inhaled Corticosteroids and Inflammatory Phenotypes in Asthma. [PDF]
Mosbech CH +10 more
europepmc +1 more source
Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study [Letter]. [PDF]
Wedzicha JA, Kiran A.
europepmc +1 more source

